2.98
price up icon1.36%   0.04
after-market Handel nachbörslich: 2.99 0.01 +0.34%
loading
Schlusskurs vom Vortag:
$2.94
Offen:
$2.93
24-Stunden-Volumen:
179.70K
Relative Volume:
0.72
Marktkapitalisierung:
$58.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-0.745
EPS:
-4
Netto-Cashflow:
$-21.66M
1W Leistung:
-7.17%
1M Leistung:
-8.59%
6M Leistung:
-15.58%
1J Leistung:
+27.90%
1-Tages-Spanne:
Value
$2.90
$3.05
1-Wochen-Bereich:
Value
$2.89
$3.2193
52-Wochen-Spanne:
Value
$1.10
$6.01

Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile

Name
Firmenname
Nrx Pharmaceuticals Inc
Name
Telefon
484-254-6134
Name
Adresse
1201 ORANGE STREET, WILMINGTON
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
NRXP's Discussions on Twitter

Vergleichen Sie NRXP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NRXP
Nrx Pharmaceuticals Inc
2.98 62.61M 0 -30.15M -21.66M -4.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-02 Eingeleitet BTIG Research Buy

Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten

pulisher
Jul 21, 2025

What analysts say about NRx Pharmaceuticals Inc. stockFree Trading Psychology Coaching - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

NRx Pharmaceuticals' Dual-Path Strategy for NRX-100: A Game-Changer in Suicidal Depression Treatment - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Charts Dual-Path for NRX-100 - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

What analysts say about NRx Pharmaceuticals Inc. Equity Warrant stockSuperior trading gains - jammulinksnews.com

Jul 21, 2025
pulisher
Jul 20, 2025

NRx Pharmaceuticals Inc. Stock Analysis and ForecastMassive wealth growth - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What drives NRx Pharmaceuticals Inc. stock priceSky-high profits - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

Is NRx Pharmaceuticals Inc. a good long term investmentBreakthrough profits - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Is NRx Pharmaceuticals Inc. Equity Warrant a good long term investmentRapid portfolio appreciation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

NRx Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastUnrivaled growth potential - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What drives NRx Pharmaceuticals Inc. Equity Warrant stock priceOutstanding stock performance - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent

Jul 18, 2025
pulisher
Jul 16, 2025

NRx Pharmaceuticals: Pioneering Mental Health Innovation Through Clinical and Operational Synergy - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment - Yahoo Finance

Jul 16, 2025
pulisher
Jul 16, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) Positioning At The Forefront Of Next-Gen Treatment - Barchart.com

Jul 16, 2025
pulisher
Jul 09, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic - The Globe and Mail

Jul 09, 2025
pulisher
Jul 08, 2025

IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic - Yahoo Finance

Jul 08, 2025
pulisher
Jun 30, 2025

Nrx Pharmaceuticals shares rise 1.23% after-hours after being added to Russell Microcap Growth Index. - AInvest

Jun 30, 2025
pulisher
Jun 27, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics - Eastern Progress

Jun 27, 2025
pulisher
Jun 26, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry Clinic - The Globe and Mail

Jun 26, 2025
pulisher
Jun 24, 2025

NRx Pharmaceuticals Files for FDA NPV Program on Behalf of NRX-100 - AInvest

Jun 24, 2025
pulisher
Jun 23, 2025

NRXP: Analyst Maintains 'Buy' Rating with Target Price Firm at $31 | NRXP Stock News - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100) - Nasdaq

Jun 23, 2025
pulisher
Jun 23, 2025

New FDA Fast-Track Program Could Accelerate Ketamine Depression Drug Approval by 10 Months - Stock Titan

Jun 23, 2025
pulisher
Jun 20, 2025

New to The Street Show #673 Airs Nationwide on Bloomberg TVSaturday, June 21 at 6:30 PM EST Featuring FLOKI, NRX Pharmaceuticals (NASDAQ:NRXP), MUSQThe Music ETF (NYSE:MUSQ), Health In Tech (NASDAQ:HIT), and Vita Bella - Detroit Free Press

Jun 20, 2025
pulisher
Jun 16, 2025

New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - The Joplin Globe

Jun 16, 2025
pulisher
Jun 16, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners - financial-news.co.uk

Jun 16, 2025
pulisher
Jun 16, 2025

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners - StreetInsider

Jun 16, 2025
pulisher
Jun 16, 2025

NRx Pharmaceuticals Taps Top Biotech IR Firm ahead of Critical FDA Filings and Clinic Acquisitions - Stock Titan

Jun 16, 2025
pulisher
Jun 15, 2025

New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP) - Livingston Daily

Jun 15, 2025
pulisher
Jun 15, 2025

NRX Pharmaceuticals: A Promising Investment with Innovative Growth and Strong Financial Outlook - TipRanks

Jun 15, 2025
pulisher
Jun 13, 2025

Safety scares and trial misses drag down neuro biotechs into Q2 - BioWorld MedTech

Jun 13, 2025
pulisher
Jun 12, 2025

NRx Pharmaceuticals CEO Set to Reveal Latest Advances at Major Neuroscience Investment Conference - Stock Titan

Jun 12, 2025
pulisher
Jun 12, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Quantisnow

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Makes New Investment in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

NRX Pharmaceuticals Submits FDA Application for NRX-100 - TipRanks

Jun 09, 2025
pulisher
Jun 07, 2025

New to The Street Signs National Media Agreement with NRx Pharmaceuticals for 12-Part Broadcast Series Across TV, Digital, and Outdoor Platforms - USA Today

Jun 07, 2025

Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
Kapitalisierung:     |  Volumen (24h):